-
Something wrong with this record ?
Neutrophils-related host factors associated with severe disease and fatality in patients with influenza infection
BM. Tang, M. Shojaei, S. Teoh, A. Meyers, J. Ho, TB. Ball, Y. Keynan, A. Pisipati, A. Kumar, DP. Eisen, K. Lai, M. Gillett, R. Santram, R. Geffers, J. Schreiber, K. Mozhui, S. Huang, GP. Parnell, M. Nalos, M. Holubova, T. Chew, D. Booth, A....
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2015
Free Medical Journals
from 2010
PubMed Central
from 2012
Europe PubMed Central
from 2012
ProQuest Central
from 2019-01-01
Open Access Digital Library
from 2015-01-01
Open Access Digital Library
from 2015-01-01
Medline Complete (EBSCOhost)
from 2012-11-01
Health & Medicine (ProQuest)
from 2019-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2010
Springer Nature OA/Free Journals
from 2010-12-01
Springer Nature - nature.com Journals - Fully Open Access
from 2010-12-01
- MeSH
- Neutrophil Activation immunology MeSH
- Cell Cycle immunology MeSH
- Influenza, Human immunology mortality pathology MeSH
- Gene Expression genetics MeSH
- Extracellular Traps immunology MeSH
- Middle Aged MeSH
- Humans MeSH
- Neutrophils immunology MeSH
- Lung immunology MeSH
- Prospective Studies MeSH
- Respiratory Insufficiency mortality pathology virology MeSH
- Respiration, Artificial MeSH
- Influenza A Virus, H1N1 Subtype immunology isolation & purification MeSH
- Influenza A Virus, H3N2 Subtype immunology isolation & purification MeSH
- Influenza B virus immunology isolation & purification MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Severe influenza infection has no effective treatment available. One of the key barriers to developing host-directed therapy is a lack of reliable prognostic factors needed to guide such therapy. Here, we use a network analysis approach to identify host factors associated with severe influenza and fatal outcome. In influenza patients with moderate-to-severe diseases, we uncover a complex landscape of immunological pathways, with the main changes occurring in pathways related to circulating neutrophils. Patients with severe disease display excessive neutrophil extracellular traps formation, neutrophil-inflammation and delayed apoptosis, all of which have been associated with fatal outcome in animal models. Excessive neutrophil activation correlates with worsening oxygenation impairment and predicted fatal outcome (AUROC 0.817-0.898). These findings provide new evidence that neutrophil-dominated host response is associated with poor outcomes. Measuring neutrophil-related changes may improve risk stratification and patient selection, a critical first step in developing host-directed immune therapy.
Biomedical Centre Medical Faculty Plzen Charles University Prague Staré Město Czech Republic
Department of Chemistry and Biochemistry Laurentian University Laurentian Canada
Department of Chemistry and Biological Chemistry Harvard University Cambridge MA USA
Department of Emergency Medicine Royal North Shore Hospital Sydney Australia
Department of Emergency Medicine St Vincent Hospital Sydney Australia
Department of Emergency Medicine Westmead Hospital Sydney Australia
Department of Intensive Care Medicine Nepean Hospital Sydney Australia
Department of Preventive Medicine University of Tennessee Health Science Centre Memphis TN USA
Genome Analytics Helmholtz Centre for Infection Research Braunschweig Germany
Otto von Guerike University of Magdeburg Clinic of Pneumology Magdeburg Germany
Sydney Informatic Hub The University of Sydney Sydney Australia
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19044616
- 003
- CZ-PrNML
- 005
- 20200113081057.0
- 007
- ta
- 008
- 200109s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41467-019-11249-y $2 doi
- 035 __
- $a (PubMed)31366921
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Tang, Benjamin M $u Department of Intensive Care Medicine, Nepean Hospital, Sydney, Australia. benjamin.tang@sydney.edu.au. Centre for Immunology and Allergy Research, The Westmead Institute for Medical Research, Sydney, Australia. benjamin.tang@sydney.edu.au. Respiratory Tract Infection Research Node, Marie Bashir Institute for Infectious Diseases and Biosecurity, Sydney, Australia. benjamin.tang@sydney.edu.au.
- 245 10
- $a Neutrophils-related host factors associated with severe disease and fatality in patients with influenza infection / $c BM. Tang, M. Shojaei, S. Teoh, A. Meyers, J. Ho, TB. Ball, Y. Keynan, A. Pisipati, A. Kumar, DP. Eisen, K. Lai, M. Gillett, R. Santram, R. Geffers, J. Schreiber, K. Mozhui, S. Huang, GP. Parnell, M. Nalos, M. Holubova, T. Chew, D. Booth, A. Kumar, A. McLean, K. Schughart,
- 520 9_
- $a Severe influenza infection has no effective treatment available. One of the key barriers to developing host-directed therapy is a lack of reliable prognostic factors needed to guide such therapy. Here, we use a network analysis approach to identify host factors associated with severe influenza and fatal outcome. In influenza patients with moderate-to-severe diseases, we uncover a complex landscape of immunological pathways, with the main changes occurring in pathways related to circulating neutrophils. Patients with severe disease display excessive neutrophil extracellular traps formation, neutrophil-inflammation and delayed apoptosis, all of which have been associated with fatal outcome in animal models. Excessive neutrophil activation correlates with worsening oxygenation impairment and predicted fatal outcome (AUROC 0.817-0.898). These findings provide new evidence that neutrophil-dominated host response is associated with poor outcomes. Measuring neutrophil-related changes may improve risk stratification and patient selection, a critical first step in developing host-directed immune therapy.
- 650 _2
- $a buněčný cyklus $x imunologie $7 D002453
- 650 _2
- $a extracelulární pasti $x imunologie $7 D065206
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a exprese genu $x genetika $7 D015870
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a virus chřipky A, podtyp H1N1 $x imunologie $x izolace a purifikace $7 D053118
- 650 _2
- $a virus chřipky A, podtyp H3N2 $x imunologie $x izolace a purifikace $7 D053122
- 650 _2
- $a virus chřipky B $x imunologie $x izolace a purifikace $7 D009981
- 650 _2
- $a chřipka lidská $x imunologie $x mortalita $x patologie $7 D007251
- 650 _2
- $a plíce $x imunologie $7 D008168
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a aktivace neutrofilů $x imunologie $7 D018375
- 650 _2
- $a neutrofily $x imunologie $7 D009504
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a umělé dýchání $7 D012121
- 650 _2
- $a respirační insuficience $x mortalita $x patologie $x virologie $7 D012131
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Shojaei, Maryam $u Department of Intensive Care Medicine, Nepean Hospital, Sydney, Australia. Centre for Immunology and Allergy Research, The Westmead Institute for Medical Research, Sydney, Australia.
- 700 1_
- $a Teoh, Sally $u Department of Intensive Care Medicine, Nepean Hospital, Sydney, Australia.
- 700 1_
- $a Meyers, Adrienne $u National HIV and Retrovirology Laboratories, JC Wilt Infectious Disease Research Centre, Public Health Agency of Canada, Department of Medical Microbiology and Infectious Disease, University of Manitoba, Winnipeg, Canada.
- 700 1_
- $a Ho, John $u National HIV and Retrovirology Laboratories, JC Wilt Infectious Disease Research Centre, Public Health Agency of Canada, Department of Medical Microbiology and Infectious Disease, University of Manitoba, Winnipeg, Canada.
- 700 1_
- $a Ball, T Blake $u National HIV and Retrovirology Laboratories, JC Wilt Infectious Disease Research Centre, Public Health Agency of Canada, Department of Medical Microbiology and Infectious Disease, University of Manitoba, Winnipeg, Canada.
- 700 1_
- $a Keynan, Yoav $u Department of Internal Medicine, Medical Microbiology and Community Health Sciences, University of Manitoba, Winnipeg, Canada.
- 700 1_
- $a Pisipati, Amarnath $u Department of Chemistry and Biological Chemistry, Harvard University, Cambridge, MA, USA.
- 700 1_
- $a Kumar, Aseem $u Department of Chemistry and Biochemistry, Laurentian University, Laurentian, Canada.
- 700 1_
- $a Eisen, Damon P $u Townsville Hospital, Townsville, Queensland, Australia.
- 700 1_
- $a Lai, Kevin $u Department of Emergency Medicine, Westmead Hospital, Sydney, Australia.
- 700 1_
- $a Gillett, Mark $u Department of Emergency Medicine, Royal North Shore Hospital, Sydney, Australia.
- 700 1_
- $a Santram, Rahul $u Department of Emergency Medicine, St. Vincent Hospital, Sydney, Australia.
- 700 1_
- $a Geffers, Robert $u Genome Analytics, Helmholtz Centre for Infection Research, Braunschweig, Germany.
- 700 1_
- $a Schreiber, Jens $u Otto-von-Guerike University of Magdeburg, Clinic of Pneumology, Magdeburg, Germany.
- 700 1_
- $a Mozhui, Khyobeni $u Department of Preventive Medicine, University of Tennessee Health Science Centre, Memphis, TN, USA.
- 700 1_
- $a Huang, Stephen $u Department of Intensive Care Medicine, Nepean Hospital, Sydney, Australia.
- 700 1_
- $a Parnell, Grant P $u Centre for Immunology and Allergy Research, The Westmead Institute for Medical Research, Sydney, Australia.
- 700 1_
- $a Nalos, Marek $u Department of Intensive Care Medicine, Nepean Hospital, Sydney, Australia. Department of Internal Medicine, Medical Faculty Plzen, Charles University Prague, Staré Město, Czech Republic.
- 700 1_
- $a Holubova, Monika $u Biomedical Centre, Medical Faculty Plzen, Charles University Prague, Staré Město, Czech Republic.
- 700 1_
- $a Chew, Tracy $u Sydney Informatic Hub, The University of Sydney, Sydney, Australia.
- 700 1_
- $a Booth, David $u Centre for Immunology and Allergy Research, The Westmead Institute for Medical Research, Sydney, Australia.
- 700 1_
- $a Kumar, Anand $u Section of Critical Care Medicine and Section of Infectious Diseases, Departments of Medicine, Medical Microbiology and Pharmacology, University of Manitoba, Winnipeg, Canada.
- 700 1_
- $a McLean, Anthony $u Department of Intensive Care Medicine, Nepean Hospital, Sydney, Australia.
- 700 1_
- $a Schughart, Klaus $u Department of Infection Genetics, Helmholtz Centre for Infection Research, Braunschweig, Germany. University of Veterinary Medicine, Hannover, Germany. Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Centre, Memphis, TN, USA.
- 773 0_
- $w MED00184850 $t Nature communications $x 2041-1723 $g Roč. 10, č. 1 (2019), s. 3422
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31366921 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200113081429 $b ABA008
- 999 __
- $a ok $b bmc $g 1482885 $s 1083289
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 10 $c 1 $d 3422 $e 20190731 $i 2041-1723 $m Nature communications $n Nat Commun $x MED00184850
- LZP __
- $a Pubmed-20200109